Back to results
US 10,087,445 B2Granted
Modifications for antisense compounds
AssigneeIntegrated Dna Technologies, Inc.
InventorsMark Aaron Behlke, Richard Owczarzy, Yong You, Joseph Alan Walder, Kim Lennox
Life of this patent
Estimating the term…
Abstract
The invention pertains to modifications for antisense oligonucleotides, wherein the modifications are used to improve stability and provide protection from nuclease degradation. The modifications could also be incorporated into double-stranded nucleic acids, such as synthetic siRNAs and miRNAs.
Claims10
A method of detecting a target oligonucleotide in a sample, the method comprising:
- (a) contacting the sample with a composition comprising a probe oligonucleotide capable of hybridizing with the target oligonucleotide, the probe oligonucleotide having the structure 5′-Y1—X—Y2-3′, wherein
- Y1 comprises a fluorophore at or near the 5′-terminus of the probe oligonucleotide and a sequence of 8-12 DNA or RNA nucleotides comprising a nucleotide N1 having a 3′ phosphate covalently linked to X;
- Y2 comprises a quencher located at or near the 3′-terminus of the probe oligonucleotide and a sequence of DNA or RNA nucleotides comprising a nucleotide N2 having a 5′ phosphate covalently linked to X;
- and
- X comprises an internal quencher;
- wherein fluorescence of the fluorophore is reduced when the probe oligonucleotide is not hybridized to the target oligonucleotide;
- and
- (b) detecting the presence of the target oligonucleotide in the sample when an increase in fluorescence of the composition is detected as compared to the fluorescence of the composition in a control sample devoid of the target oligonucleotide.
5 more elements
Dependencies are inferred from the claim text.